Cover Image

Chemocine receptor CXCR4 expression and microvessels density in malignant tumors of the breast of patients with sings of metabolic syndrome

Saved in:

Bibliographic Details
Date:	2020
Main Authors:	N. P. Yurchenko, I. P. Nesina, O. V. Brieieva, V. F. Chekhun, L. H. Buchynska
Format:	Article
Language:	English
Published:	2020
Series:	Oncology
Online Access:	http://jnas.nbuv.gov.ua/article/UJRN-0001149914
Tags:	Add Tag No Tags, Be the first to tag this record!
Journal Title:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Similar Items

Tumor-associated macrophages, FOXP3+-lymphocytes and microvessel density in endometrial carcinoma of patients with various menstrual status
by: I. P. Nesina, et al.
Published: (2017)

Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
by: S. M. Hrybach, et al.
Published: (2018)

Informative resource &quot;Hereditary cancer syndromes&quot; as element of primary prophylaxis and early diagnostics of malignant tumors
by: L. H. Buchynska, et al.
Published: (2015)

Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
by: Grybach, S.M., et al.
Published: (2018)

Clinical significance of hormonal receptor status of malignant ovarian tumors
by: I. G. Tkalia, et al.
Published: (2014)

Clinical significance of hormonal receptor status of malignant ovarian tumors
by: Tkalia, I.G., et al.
Published: (2014)

Relationship between malignant tumor metabolism and tumor-bearing organism
by: T. N. Popovskaja, et al.
Published: (2019)

The spectrum of blood serum lipids in patients with breast cancer without metabolic syndrome
by: Timovska, Yu., et al.
Published: (2011)

Protein and carbohydrate metabolism disorders in patients with malignant tumors of the intestine
by: T. N. Popovskaja, et al.
Published: (2018)

Determination of individual genetic risk of malignant tumors in relatives of endometrial cancer patients
by: L. H. Buchynska, et al.
Published: (2018)

Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
by: D. Y. Tsyhyka, et al.
Published: (2013)

Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
by: Tsyhyka, D.Y., et al.
Published: (2013)

Expression of proteins of polyamine metabolism ferments in human prostate malignant tumors
by: S. V. Hohol
Published: (2019)

Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: S. V. Chekhun, et al.
Published: (2014)

Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: Chekhun, S.V., et al.
Published: (2014)

Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors
by: Bereznaya, N.M., et al.
Published: (2008)

Cytomegaloviruses and malignant brain tumors
by: Lisyany, N.I., et al.
Published: (2023)

Influence of ferromagnetic nanocomposite (Ferroplat) on human breast cancer cells of different malignancy degrees: pro/antioxidant balance and energy metabolism
by: Chekhun, V.F., et al.
Published: (2018)

Spike protein of SARS-Cov-2 increases the expression of CXCR4 in breast cancer cells and their migration
by: Shlapatska, Larysa
Published: (2026)

Expression analisis of the ITSN2 and TKS5 mRNA isoforms in human malignant breast tumors
by: S. V. Kropyvko, et al.
Published: (2018)

Metabolic syndrome is inversely related to soluble receptor for advanced glycation end products: a study in mother-infant pairs
by: Klenovicsova, K., et al.
Published: (2011)

Reprogramming of mitochondrial energy metabolism in malignant neoplasms
by: A. A. Kaplja, et al.
Published: (2015)

Hodgkin’s lymphoma: the role of cell surface receptors in regulation of tumor cell fate
by: Yurchenko, M., et al.
Published: (2010)

Nanohyperthermia of malignant tumors. II. In vivo tumor heating with manganese perovskite nanoparticles
by: Bubnovskaya, L., et al.
Published: (2012)

Indicators of lipid metabolism disorders in the blood serum of adolescents with metabolic syndrome
by: L. A. Strashok, et al.
Published: (2020)

The phenomenon of multi-drug resistance in the treatment of malignant tumors
by: Vtorushin, S.V., et al.
Published: (2014)

The phenomenon of multi-drug resistance in the treatment of malignant tumors
by: S. V. Vtorushin, et al.
Published: (2014)

Vacuum cryo-thermal probe for destruction of malignant tumors
by: M. I. Gasanov, et al.
Published: (2013)

Laboratory parameters as predictors of bladder tumor malignancy grade
by: L. A. Derzhavets
Published: (2013)

The peculiarities of gene expression of medullary breast carcinoma tumor-associated antigens in different types of breast tumors
by: Shyian, А., et al.
Published: (2012)

The peculiarities of gene expression of medullary breast carcinoma tumor-associated antigensin different types of breast tumors
by: M. A. Shyian, et al.
Published: (2012)

Expression of markers of intercellular adhesion CD44 and CD24 in cells of endometrial carcinoma with high malignancy potential
by: I. P. Nesina, et al.
Published: (2019)

Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
by: Lukianova, N.Yu., et al.
Published: (2023)

Application of Information Technology for Determination of Circulating Tumor Cells to Diagnostics of Malignant Tumor Diseases
by: Yu. Azarkhov, et al.
Published: (2020)

Modern view on the problem of metabolic syndrome (review)
by: Yu. M. Hryshko
Published: (2018)

Therapeutic correction of atherogenic dyslipidemia at metabolic syndrome
by: T. N. Ambrosova
Published: (2013)

Endocrine status of patients with osteoarthritis and metabolic syndrome
by: L. N. Yefremenkova
Published: (2015)

The effect of metabolic syndrome on prostatic cancer development
by: T. A. Nalbandjan
Published: (2016)

Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
by: Yalovenko, T.M., et al.
Published: (2016)

Genetic and epigenetic changes in malignant cells of tumors of urogenital organs
by: Gordiyuk, V.V.
Published: (2010)